Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Clinical outcomes associated with sickle cell trait: A systematic review
source: Annals of internal medicine
year: 2018
authors: Naik RP, Smith-Whitley K, Hassell KL, Umeh NI, de Montalembert M, Sahota P, Haywood C Jr, Jenkins J, Lloyd-Puryear MA, Joiner CH, Bonham VL, Kato GJ
summary/abstract:Background:
Although sickle cell trait (SCT) is largely a benign carrier state, it may increase risk for certain clinical outcomes.
Purpose:
To evaluate associations between SCT and clinical outcomes in children and adults.
Data Sources:
English-language searches of PubMed, CINAHL, the Cochrane Library, Current Contents Connect, Scopus, and Embase (1 January 1970 to 30 June 2018) and bibliographies of review articles.
Study Selection:
Observational controlled studies (published in English) in children or adults that examined an association between SCT and any of 24 clinical outcomes specified a priori in the following 6 categories: exertion-related injury; renal, vascular, pediatric, and surgery- or trauma-related outcomes; and overall mortality.
Data Extraction:
A single reviewer extracted study data, which was checked by another; 2 reviewers independently assessed study quality; and strength of evidence was assessed by consensus.
Data Synthesis:
Of 7083 screened studies, 41 met inclusion criteria. High-strength evidence supported a positive association between SCT and risk for pulmonary embolism, proteinuria, and chronic kidney disease. Moderate-strength evidence supported a positive association between SCT and exertional rhabdomyolysis and a null association between SCT and deep venous thrombosis, heart failure or cardiomyopathy, stroke, and pediatric height or weight. Absolute risks for thromboembolism and rhabdomyolysis were small. For the remaining 15 clinical outcomes, data were insufficient or strength of evidence was low.
Limitation:
Publication bias was possible, and high-quality evidence was scant.
Conclusion:
Sickle cell trait is a risk factor for a few adverse health outcomes, such as pulmonary embolism, kidney disease, and exertional rhabdomyolysis, but does not seem to be associated with such complications as heart failure and stroke. Insufficient data or low-strength evidence exists for most speculated complications of SCT.
DOI: 10.7326/M18-1161
read more full text
Related Content
-
Do I Have Sickle Cell Trait?Sickle cell disease is a genetic blood d...
-
Ty Montgomery says he’s not worried about sickle cell traitThe symptoms that kept Ty Montgomery out...
-
Malaria-Driven Sickle Cell Trait Selection – Evidence for Modern Day Human Evolution?Sickle cell disease poses a serious heal...
-
The current state of sickle-cell trait: Implications for reproductive and genetic counselingSickle cell trait (SCT) is unique among ...
-
New Jersey may start a confidential sickle cell trait registryThe New Jersey Legislature is considerin...
-
Black Americans With Sickle Cell Trait At Increased Risk Of Kidney DiseaseAfrican Americans with sickle cell trait...
-
Cardinals’ Bruce Arians: WR John Brown carries sickle-cell traitA blood test Thursday revealed that Ariz...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.